The Tumor Immunotherapy Program (TIP) at the Princess Margaret Cancer Centre is the first program of its kind in Canada and one of a handful around the world. Our team is made up of experts in the fields of immunology, oncology, genomics, bioinformatics, pathology, and surgery.
TIP is directed by Dr. Pamela Ohashi, a world-renowned basic and translational immunologist, and Dr. Lillian Siu who integrates TIP with two other key programs at the Princess Margaret: the Drug Development Program (DDP) and Cancer Genomics Program (CGP). These three programs form a synergistic triad that supports the Princess Margaret Cancer Centre’s core vision to deliver precision cancer medicine.
The four key research domains of TIP include:
- Discovery research
- Investigator-initiated clinical studies
- Sponsored clinical studies
- Health services and outcomes research
